![]()
|
|
||||||||
J. Biol. Chem., Vol. 269, Issue 42, 26083-26091, 10, 1994
C Frey, K Narayanan, K McMillan, L Spack, SS Gross, BS Masters and OW Griffith
Nitric-oxide synthase (NOS) catalyzes the oxidation of L-arginine to
citrulline and nitric oxide (NO). The enzyme is inhibited by a variety of N
omega-monosubstituted L-arginine analogs, and some of these compounds are
useful in reversing pathologies associated with the overproduction of NO
(e.g. the hypotension of septic shock). We report here that
L-thiocitrulline (gamma-thioureido-L-norvaline) is a potent, stereospecific
inhibitor of the constitutive brain and endothelial isoforms of NOS as well
as the isoform induced in vascular smooth muscle cells by
lipopolysaccharide and interferon-gamma. Steady state kinetic studies show
L-thiocitrulline inhibition is competitive with L- arginine (Ki
approximately 4-20% of KArgm), indicating that initial binding is as a
substrate/product analog. In contrast to L-arginine and N
omega-methyl-L-arginine, the prototypic NOS inhibitor, L- thiocitrulline
binding elicits a "Type II" difference spectrum, indicating a high spin to
low spin transition of the iron in the heme cofactor. This finding suggests
that L-thiocitrulline is contributing the sixth ligand to heme iron,
probably through the thioureido sulfur. Such interaction with heme iron
neither stimulates nor inhibits the direct flavin-mediated cytochrome c
reduction activity of the enzyme, but it does inhibit heme-dependent
superoxide formation. In vivo, L- thiocitrulline is a potent pressor agent
in both normal and endotoxemic rats, the latter finding suggesting utility
in treating the hypotension of septic shock.
L-thiocitrulline. A stereospecific, heme-binding inhibitor of nitric- oxide synthases
Department of Biochemistry, Medical College of Wisconsin, Milwaukee 53226.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
B. R. Babu, C. Frey, and O. W. Griffith L-Arginine Binding to Nitric-oxide Synthase. THE ROLE OF H-BONDS TO THE NONREACTIVE GUANIDINIUM NITROGENS J. Biol. Chem., September 3, 1999; 274(36): 25218 - 25226. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Gunnett, Y. Chu, D. D. Heistad, A. Loihl, and F. M. Faraci Vascular effects of LPS in mice deficient in expression of the gene for inducible nitric oxide synthase Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H416 - H421. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Babu and O. W. Griffith N5-(1-Imino-3-butenyl)-L-ornithine. A NEURONAL ISOFORM SELECTIVE MECHANISM-BASED INACTIVATOR OF NITRIC OXIDE SYNTHASE J. Biol. Chem., April 10, 1998; 273(15): 8882 - 8889. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Garcia-Cardena, P. Martasek, B. S. S. Masters, P. M. Skidd, J. Couet, S. Li, M. P. Lisanti, and W. C. Sessa Dissecting the Interaction between Nitric Oxide Synthase (NOS) and Caveolin. FUNCTIONAL SIGNIFICANCE OF THE NOS CAVEOLIN BINDING DOMAIN IN VIVO J. Biol. Chem., October 10, 1997; 272(41): 25437 - 25440. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Moncada, A. Higgs, and R. Furchgott XIV. International Union of Pharmacology Nomenclature in Nitric Oxide Research Pharmacol. Rev., June 1, 1997; 49(2): 137 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-F. Chen, A.-L. Tsai, V. Berka, and K. K. Wu Mutation of Glu-361 in Human Endothelial Nitric-oxide Synthase Selectively Abolishes L-Arginine Binding without Perturbing the Behavior of Heme and Other Redox Centers J. Biol. Chem., March 7, 1997; 272(10): 6114 - 6118. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Berka, P.-F. Chen, and A.-L. Tsai Spatial Relationship between L-Arginine and Heme Binding Sites of Endothelial Nitric-oxide Synthase J. Biol. Chem., December 27, 1996; 271(52): 33293 - 33300. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gachhui, A. Presta, D. F. Bentley, H. M. Abu-Soud, R. McArthur, G. Brudvig, D. K. Ghosh, and D. J. Stuehr Characterization of the Reductase Domain of Rat Neuronal Nitric Oxide Synthase Generated in the Methylotrophic Yeast Pichia pastoris. CALMODULIN RESPONSE IS COMPLETE WITHIN THE REDUCTASE DOMAIN ITSELF J. Biol. Chem., August 23, 1996; 271(34): 20594 - 20602. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Salerno, C. Frey, K. McMillan, R. F. Williams, B. S. S. Masters, and O. W. Griffith Characterization by Electron Paramagnetic Resonance of the Interactions of L-Arginine and L-Thiocitrulline with the Heme Cofactor Region of Nitric Oxide Synthase J. Biol. Chem., November 17, 1995; 270(46): 27423 - 27428. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Pritchard Jr, L. Groszek, D. M. Smalley, W. C. Sessa, M. Wu, P. Villalon, M. S. Wolin, and M. B. Stemerman Native Low-Density Lipoprotein Increases Endothelial Cell Nitric Oxide Synthase Generation of Superoxide Anion Circ. Res., September 1, 1995; 77(3): 510 - 518. [Abstract] [Full Text] |
||||
![]() |
J. Santolini, S. Adak, C. M. L. Curran, and D. J. Stuehr A Kinetic Simulation Model That Describes Catalysis and Regulation in Nitric-oxide Synthase J. Biol. Chem., January 5, 2001; 276(2): 1233 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kotsonis, L. G. Frohlich, C. S. Raman, H. Li, M. Berg, R. Gerwig, V. Groehn, Y. Kang, N. Al-Masoudi, S. Taghavi-Moghadam, et al. Structural Basis for Pterin Antagonism in Nitric-oxide Synthase. DEVELOPMENT OF NOVEL 4-OXO-PTERIDINE ANTAGONISTS OF (6R)-5,6,7,8-TETRAHYDROBIOPTERIN J. Biol. Chem., December 21, 2001; 276(52): 49133 - 49141. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |